Stockscreener 앱 받기
16.26
4.18%
-0.71
시간 외 거래:
16.26
전일 마감가:
$16.97
열려 있는:
$16.5
하루 거래량:
551.67K
Relative Volume:
1.00
시가총액:
$980.08M
수익:
$1.23M
순이익/손실:
$-214.90M
주가수익비율:
-3.9445
EPS:
-4.1222
순현금흐름:
$-151.25M
1주 성능:
-8.60%
1개월 성능:
+4.97%
6개월 성능:
-29.27%
1년 성능:
-39.60%
1일 변동 폭
$16.23
$17.04
1주일 범위
$16.23
$18.00
52주 변동 폭
$10.91
$40.26
Spyre Therapeutics Inc Stock (SYRE) Company Profile
명칭
Spyre Therapeutics Inc
전화
(617) 651-5940
주소
221 CRESCENT STREET, WALTHAM
SYRE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SYRE
Spyre Therapeutics Inc
|
16.26 | 1.02B | 1.23M | -214.90M | -151.25M | -4.1222 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Spyre Therapeutics Inc Stock (SYRE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-08 | 개시 | Leerink Partners | Outperform |
| 2025-03-18 | 개시 | Wolfe Research | Outperform |
| 2024-09-04 | 개시 | Wedbush | Outperform |
| 2024-07-16 | 개시 | Evercore ISI | Outperform |
| 2024-05-02 | 개시 | Robert W. Baird | Outperform |
| 2024-03-01 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-12-20 | 개시 | BTIG Research | Buy |
| 2023-12-11 | 개시 | Guggenheim | Buy |
| 2023-12-11 | 개시 | Jefferies | Buy |
| 2020-05-04 | 개시 | Piper Sandler | Overweight |
| 2019-03-21 | 개시 | JP Morgan | Overweight |
| 2018-09-04 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2018-04-24 | 개시 | Evercore ISI | Outperform |
| 2018-03-14 | 재확인 | Needham | Buy |
모두보기
Spyre Therapeutics Inc 주식(SYRE)의 최신 뉴스
How hedge fund analytics apply to Spyre Therapeutics Inc. stockFree Trade Insight With Community Collaboration - Newser
Market reaction to Spyre Therapeutics Inc.’s recent newsTrade Alert System with Volume Analysis - Newser
Visual trend scoring systems applied to Spyre Therapeutics Inc.Machine Learning Stock Price Forecast Tool - Newser
What are analysts’ price targets for Spyre Therapeutics Inc. in the next 12 monthsTop Growth Alerts For Smart Trading - jammulinksnews.com
Using flow based indicators on Spyre Therapeutics Inc.Free Daily Volume Spike Trading Signals - Newser
Is Spyre Therapeutics Inc. a growth stock or a value stockFree Stock Alerts For Every Investor - jammulinksnews.com
Spyre Therapeutics Announces Grants of Inducement Awards - The Manila Times
Spyre Therapeutics Announces Grants of Inducement Awards - GlobeNewswire Inc.
Is it the right time to buy Spyre Therapeutics Inc. stockPost Market Outlook For Smart Trading - jammulinksnews.com
Is Spyre Therapeutics Inc. stock overvalued or undervaluedMarket Forecast Target Finder For Every Investor - jammulinksnews.com
Intraday pattern recognizer results for Spyre Therapeutics Inc.Free Multi-Bagger Potential Stock Forecast Tools - Newser
Analyzing drawdowns of Spyre Therapeutics Inc. with statistical toolsTechnical Reversal Setup with Risk Limits - Newser
Identifying reversal signals in Spyre Therapeutics Inc.ROI Focused Setup Screener With Exit Markers - Newser
What moving averages say about Spyre Therapeutics Inc.Weekly Outlook for Short Term Investors - Newser
Moving Average Trends for Spyre Therapeutics Inc. Stock: What They IndicateBuy Point Strategy with Profit Protection - Newser
How strong is Spyre Therapeutics Inc. company’s balance sheetBreakout Stocks Tracker For Consistent Profits - jammulinksnews.com
What catalysts could drive Spyre Therapeutics Inc. stock higher in 2025Free Stock Watchlist For Fast Growth - jammulinksnews.com
Why Spyre Therapeutics Inc. stock attracts strong analyst attentionFree Access to Real-Time Trade Insights - Newser
Will a bounce in Spyre Therapeutics Inc. offer an exitFree Community Shared Smart Money Signals - Newser
What is the dividend policy of Spyre Therapeutics Inc. stockWealth Building Trend Scanner For 2025 - jammulinksnews.com
Can momentum traders help lift Spyre Therapeutics Inc.Short-Term Bounce Forecast for Oversold Stocks - Newser
Spyre Therapeutics Inc. stock trend outlook and recovery pathBuy Signal System Based on Price Action - Newser
How to track smart money flows in Spyre Therapeutics Inc.Buy Signal System Based on Price Action - Newser
Sector ETF Data Correlates with Strength in Spyre Therapeutics Inc.Intraday Trend Analysis for Fast Gains Released - metal.it
Trading Bots Trigger Alerts on Spyre Therapeutics Inc. ActivityCapital Growth With Controlled Risk Picks Suggested - metal.it
How Resilient Is Spyre Therapeutics Inc. Stock During Economic DownturnsChart Breakout Buy Signal Detection Confirmed - metal.it
Published on: 2025-07-29 08:11:08 - metal.it
What are the technical indicators suggesting about Spyre Therapeutics Inc.Post Market Opportunities For Consistent Profits - jammulinksnews.com
How does Spyre Therapeutics Inc. compare to its industry peersSwing Trade Target Finder With Low Risk - jammulinksnews.com
Published on: 2025-07-28 20:59:32 - metal.it
How volatile is Spyre Therapeutics Inc. stock compared to the marketBreakout Stocks Tracker With High Returns - jammulinksnews.com
Published on: 2025-07-28 18:29:12 - metal.it
Victory Capital Management Inc. Sells 16,230 Shares of Spyre Therapeutics, Inc. (NASDAQ:SYRE) - Defense World
How Resilient Is Spyre Therapeutics Inc. Stock During Economic Downturns AI Trading Forecast Based on Big Data - Newser
Market reaction to Spyre Therapeutics Inc.’s recent news Free Quick Gain Stock Watch With Indicators - metal.it
What makes Spyre Therapeutics Inc. stock price move sharplyExplosive portfolio gains - jammulinksnews.com
Spyre Therapeutics Inc (SYRE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.93%
0.15%
자본화:
|
볼륨(24시간):